These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15277256)

  • 1. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
    Brockstein B; Haraf DJ; Rademaker AW; Kies MS; Stenson KM; Rosen F; Mittal BB; Pelzer H; Fung BB; Witt ME; Wenig B; Portugal L; Weichselbaum RW; Vokes EE
    Ann Oncol; 2004 Aug; 15(8):1179-86. PubMed ID: 15277256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
    Argiris A; Haraf DJ; Kies MS; Vokes EE
    Oncologist; 2003; 8(4):350-60. PubMed ID: 12897332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
    Salama JK; Stenson KM; Kistner EO; Mittal BB; Argiris A; Witt ME; Rosen F; Brockstein BE; Cohen EE; Haraf DJ; Vokes EE
    Ann Oncol; 2008 Oct; 19(10):1787-94. PubMed ID: 18539617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
    Vokes EE; Kies MS; Haraf DJ; Stenson K; List M; Humerickhouse R; Dolan ME; Pelzer H; Sulzen L; Witt ME; Hsieh YC; Mittal BB; Weichselbaum RR
    J Clin Oncol; 2000 Apr; 18(8):1652-61. PubMed ID: 10764425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
    Vokes EE; Stenson K; Rosen FR; Kies MS; Rademaker AW; Witt ME; Brockstein BE; List MA; Fung BB; Portugal L; Mittal BB; Pelzer H; Weichselbaum RR; Haraf DJ
    J Clin Oncol; 2003 Jan; 21(2):320-6. PubMed ID: 12525525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
    Mantz CA; Vokes EE; Stenson K; Kies MS; Mittal B; Witt ME; List MA; Weichselbaum RR; Haraf DJ
    Cancer J; 2001; 7(2):140-8. PubMed ID: 11324767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
    Mantz CA; Vokes EE; Kies MS; Mittal B; Witt ME; List MA; Weichselbaum RR; Haraf DJ
    Ann Oncol; 2001 Mar; 12(3):343-7. PubMed ID: 11332146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
    Oh JL; Vokes EE; Kies MS; Mittal BB; Witt ME; Weichselbaum RR; Haraf DJ
    Ann Oncol; 2003 Apr; 14(4):564-9. PubMed ID: 12649102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
    Haddad R; O'Neill A; Rabinowits G; Tishler R; Khuri F; Adkins D; Clark J; Sarlis N; Lorch J; Beitler JJ; Limaye S; Riley S; Posner M
    Lancet Oncol; 2013 Mar; 14(3):257-64. PubMed ID: 23414589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
    Seiwert TY; Melotek JM; Blair EA; Stenson KM; Salama JK; Witt ME; Brisson RJ; Chawla A; Dekker A; Lingen MW; Kocherginsky M; Villaflor VM; Cohen EE; Haraf DJ; Vokes EE
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):21-9. PubMed ID: 27511844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
    Kies MS; Haraf DJ; Rosen F; Stenson K; List M; Brockstein B; Chung T; Mittal BB; Pelzer H; Portugal L; Rademaker A; Weichselbaum R; Vokes EE
    J Clin Oncol; 2001 Apr; 19(7):1961-9. PubMed ID: 11283128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
    Cohen EE; Haraf DJ; List MA; Kocherginsky M; Mittal BB; Rosen F; Brockstein B; Williams R; Witt ME; Stenson KM; Kies MS; Vokes EE
    J Clin Oncol; 2006 Jul; 24(21):3438-44. PubMed ID: 16849759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concurrent chemoradiotherapy for head and neck squamous cell carcinoma with indication of total laryngectomy].
    Kubota A; Furukawa M; Komatsu M
    Nihon Jibiinkoka Gakkai Kaiho; 2004 Nov; 107(11):1004-10. PubMed ID: 15624506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials.
    Cheng SH; Yen KL; Jian JJ; Tsai SY; Chu NM; Leu SY; Chan KY; Tan TD; Cheng JC; Hsieh CY; Huang AT
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):717-26. PubMed ID: 11395240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
    Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
    J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.